Evidence map›Paper›PMID 34556249›Full record

ReviewDermatologic clinics2021

The Impact of COVID-19 on Teledermatology: A Review.

Cassandra B Yeboah, Nailah Harvey, Rohan Krishnan, Jules B Lipoff

Abstract readReview
In one paragraph

Review in Dermatologic clinics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Trial
  2. Implementation of Direct-to-Patient Mobile Teledermatology in VA.Journal of general internal medicine · 2024
    Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Image Quality Assessment Using Convolutional Neural Network in Clinical Skin Images.JID innovations : skin science from molecules to population health · 2024
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Teledermatology: A useful tool also after COVID-19 era?Journal of cosmetic dermatology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Cassandra B YeboahPhiladelphia College of Osteopathic Medicine, 4170 City Avenue, Philadelphia, PA 19131, USA.
Nailah HarveyPhiladelphia College of Osteopathic Medicine, 4170 City Avenue, Philadelphia, PA 19131, USA.
Rohan KrishnanDepartment of Dermatology, Perelman School of Medicine, University of Pennsylvania, 4170 City Avenue, Philadelphia, PA 19131, USA.
Jules B LipoffDepartment of Dermatology, Perelman School of Medicine, University of Pennsylvania, 4170 City Avenue, Philadelphia, PA 19131, USA; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: jules.lipoff@pennmedicine.upenn.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The accelerated implementation and use of teledermatology during the coronavirus disease 2019 pandemic has met with successes and challenges. This review explores how telemedicine was used in dermatology before the pandemic, the regulatory adaptions made in response to the pandemic, and the effectiveness of the rapid implementation of teledermatology during the coronavirus disease 2019 pandemic, and, finally, how teledermatology has expanded in response to the pandemic. This review examines lessons learned and how teledermatology's reliance on digital technologies might paradoxically exacerbate health care disparities, and finally, considers the future outlook.

Indexed as

COVID-19DermatologyHumansReferral and ConsultationRemote ConsultationSeverity of Illness IndexSkin DiseasesTelemedicineCOVID-19Digital divideLive-interactive teledermatologyStore-and-forward teledermatologyTeledermatologyTelehealthTelemedicine

Identifiers

PMID34556249
PMCPMC8162710

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.